Hyo Suk Nam Selected Research

Rosuvastatin Calcium (Crestor)

5/2023	Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial.
1/2016	Effect and Safety of Rosuvastatin in Acute Ischemic Stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyo Suk Nam Research Topics

Disease

77	Stroke (Strokes) 04/2024 - 01/2007
49	Ischemic Stroke 11/2023 - 01/2007
17	Thrombosis (Thrombus) 12/2023 - 10/2011
9	Atrial Fibrillation 01/2024 - 03/2015
6	Neoplasms (Cancer) 12/2023 - 01/2019
6	Embolism (Embolus) 05/2022 - 01/2007
6	Cerebral Infarction 01/2021 - 08/2012
5	Atherosclerosis 01/2024 - 09/2012
5	Hemorrhage 01/2021 - 11/2010
5	Myocardial Infarction 01/2021 - 11/2010
4	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2023 - 12/2013
4	Pathologic Constriction (Stenosis) 01/2023 - 01/2007
4	Brain Ischemia (Cerebral Ischemia) 07/2021 - 08/2013
4	Infarction (Infarctions) 03/2020 - 01/2007
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2020 - 08/2013
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 10/2017
4	Hypertension (High Blood Pressure) 01/2018 - 01/2009
3	Carotid Stenosis (Carotid Artery Stenosis) 01/2022 - 10/2011
3	Cerebral Hemorrhage 01/2020 - 01/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 10/2017
3	Inflammation (Inflammations) 05/2019 - 12/2012
3	Lacunar Stroke 01/2016 - 01/2013
2	Heart Failure 12/2023 - 05/2022
2	Transient Ischemic Attack 01/2023 - 03/2015
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2023 - 10/2015
2	Embolic Stroke 05/2022 - 07/2015
2	Unstable Angina 01/2019 - 10/2017
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2016 - 04/2013
2	Diabetes Mellitus 01/2012 - 04/2009
1	Carotid Artery Thrombosis 11/2022
1	Acute Coronary Syndrome 05/2022
1	Leukopenia 10/2021
1	Vascular Diseases (Vascular Disease) 02/2021
1	COVID-19 01/2021
1	Cognitive Dysfunction 01/2021
1	Brain Edema (Cerebral Edema) 03/2020
1	Hemorrhagic Stroke 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2019
1	Overweight 01/2019
1	Apnea 01/2019
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2019

Drug/Important Bio-Agent (IBA)

8	omega-Chloroacetophenone (Mace)IBA 01/2024 - 10/2017
8	danaparoid (Orgaran)FDA Link 01/2022 - 01/2007
8	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 11/2010
6	AnticoagulantsIBA 01/2024 - 01/2018
6	Cilostazol (Pletal)FDA LinkGeneric 01/2021 - 01/2013
5	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2013
4	Vitamin K FDA Link 07/2021 - 01/2018
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2020 - 11/2010
4	CalciumIBA 01/2020 - 09/2013
4	Biomarkers (Surrogate Marker)IBA 05/2019 - 08/2012
3	LDL CholesterolIBA 05/2023 - 01/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2023 - 01/2016
3	ferric chlorideIBA 11/2022 - 01/2013
3	Dabigatran FDA Link 01/2020 - 10/2017
3	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2018 - 07/2015
2	Blood Coagulation Factors (Coagulation Factor)IBA 12/2023 - 07/2022
2	fibrin fragment D (D-dimer)IBA 09/2023 - 08/2015
2	oxidized low density lipoproteinIBA 05/2023 - 01/2023
2	Rosuvastatin Calcium (Crestor)FDA Link 05/2023 - 01/2016
2	FibrinIBA 11/2021 - 12/2016
2	N(4)-oleylcytosine arabinosideIBA 07/2021 - 01/2018
2	Probucol (Lorelco)FDA Link 01/2021 - 01/2020
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 01/2020
2	trimethyloxamine (trimethylamine N-oxide)IBA 09/2019 - 05/2019
2	Oxygen (Dioxygen)IBA 01/2019 - 08/2013
2	SolutionsIBA 01/2018 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 01/2015
2	Indicators and Reagents (Reagents)IBA 10/2014 - 09/2012
2	OsteoprotegerinIBA 08/2013 - 12/2012
2	CholesterolIBA 01/2012 - 04/2009
1	Thrombin FDA Link 12/2023
1	Factor X (Stuart Factor)IBA 12/2023
1	IodineIBA 11/2023
1	Ezetimibe (Zetia)FDA Link 05/2023
1	ApolipoproteinsIBA 01/2023
1	LipidsIBA 01/2023
1	Apolipoproteins B (ApoB)IBA 01/2023
1	Histones (Histone)IBA 11/2022
1	Interleukin-17 (Interleukin 17)IBA 07/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2022
1	Saline SolutionIBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	fimasartanIBA 07/2021
1	Antihypertensive Agents (Antihypertensives)IBA 07/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2021
1	Testosterone (Sustanon)FDA Link 02/2021
1	salicylhydroxamic acid (SHAM)IBA 03/2020
1	Acetazolamide (Diamox)FDA LinkGeneric 03/2020
1	Aquaporin 4IBA 03/2020
1	RivaroxabanIBA 01/2020

Therapy/Procedure

29	Thrombectomy 04/2024 - 07/2015
21	Therapeutics 12/2022 - 01/2011
8	Stents 01/2019 - 10/2011
5	Thrombolytic Therapy 02/2024 - 09/2010
3	Wearable Electronic Devices 01/2023 - 01/2017
2	Length of Stay 01/2023 - 08/2016
2	Punctures 01/2021 - 01/2016
2	Secondary Prevention 09/2017 - 06/2015